MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0068786
Janveda Formulation Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.86 Lakh
▼ 68% YoY
Net loss · FY 2025
₹5.35 Lakh
Net margin -19.2%
EBITDA · FY 2025
-₹97,480
EBITDA margin -3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹23 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Janveda Formulation Private Limited
Data last updated:
Janveda Formulation Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2019PTC105848. Its GSTIN is 24AAECJ4329C1ZZ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tusharbhai Babubhai Mangukiya and Prakashbhai Kalubhai Goti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed 54 Silver Industrial Estate – 2 Nr. Nova Industries Changodar, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.86 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹5.35 Lakh (net margin -19.2%) and EBITDA of -₹97,480 (EBITDA margin -3.5%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 15% over five years.
The company is associated with 1 brand: Janveda. As per MCA filings, the company has open charges of ₹23 Lakh on record.
Janveda Formulation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0068786). For more details, the company can be reached via its website janveda.com.
Company Details of Janveda Formulation Private Limited
CIN U74999GJ2019PTC105848
Registration Number 105848
Incorporation Date 03 January 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0068786
Recognitions & Rankings of Janveda Formulation
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShed 54 Silver Industrial Estate – 2 Nr. Nova Industries Changodar, Ahmedabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Janveda Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Janveda Formulation Private Limited
Janveda Formulation operates one associated brand: Janveda. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and distribution with a focus on healthcare values in India. | janveda.com |
Business Activity of Janveda Formulation Private Limited
The main business activity of Janveda Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Janveda Formulation Private Limited FY 2025 filings available
Janveda Formulation Private Limited reported revenue of ₹27.86 Lakh (down 68% YoY) for FY 2025.
Revenue · FY 2025
₹27.86 Lakh ▼ 68%
Net loss · FY 2025
₹5.35 Lakh margin -19.2%
EBITDA · FY 2025
-₹97,480 margin -3.5%
Compounded Annual Growth Rate (CAGR) of Janveda Formulation Private Limited
Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 33%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 126%
3 years · compounded
▼ 32%
5 years · compounded
▼ 24%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 68% fall in the latest year. EBITDA fell 126% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Janveda Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹97,480 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹5.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Janveda Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -19.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Janveda Formulation are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Janveda Formulation Private Limited
Janveda Formulation has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tusharbhai Babubhai Mangukiya Also directs: Janveda Healthceutical Private Limited, Janveda Federation | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
| Prakashbhai Kalubhai Goti | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
Peer Comparison of Janveda Formulation Private Limited
Janveda Formulation Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Newnano Technologies Private Limited | ₹28.03 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Mumbai, Maharashtra, India |
| Rising Flora Biotech Private Limited | ₹27.99 Lakh (FY 2024) | •••• | •••• | 9.0% | •••• | Jalgaon, Maharashtra, India |
| Valasys Lifesciences Private Limited | ₹27.91 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Pune, Maharashtra, India |
| Clear Gems Private Limited | ₹27.91 Lakh (FY 2025) | •••• | •••• | -39.0% | •••• | Mumbai, Maharashtra, India |
| Gale Pharma (India) Private Limited | ₹27.87 Lakh (FY 2020) | •••• | •••• | -67.0% | •••• | Hyderabad, Telangana, India |
| Janveda Formulation Private Limited this company | ₹27.86 Lakh (FY 2025) | •••• | •••• | -68.0% | •••• | Ahmedabad, Gujarat, India |
| KRH Healthcare Private Limited | ₹27.84 Lakh (FY 2023) | •••• | •••• | -58.0% | •••• | Nashik, Maharashtra, India |
| Musita Health Care Private Limited | ₹27.83 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Allahabad, Uttar Pradesh, India |
| Ceymco Global Private Limited | ₹27.81 Lakh (FY 2021) | •••• | •••• | 33.0% | •••• | Chennai, Tamil Nadu, India |
| Genovision Labs Private Limited | ₹27.79 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Pendulum Lifesciences Private Limited | ₹27.73 Lakh (FY 2018) | •••• | •••• | -24.0% | •••• | Madurai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Janveda Formulation by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Janveda Formulation Private Limited
Janveda Formulation Private Limited is audited by Fenil P Shah and Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Fenil P Shah and Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Janveda Formulation Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Janveda Formulation Private Limited
Open charges
₹23 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2024 | Others | ₹23 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Janveda Formulation Private Limited
Employment history and EPFO contributions of people linked to Janveda Formulation.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Janveda Formulation Private Limited
Janveda Formulation Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Mayur Natvarlal Devani ceased to be Additional Director on 01 Apr 2023.
AGM
Janveda Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Janveda Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 23.00 Lakh with Charge ID 100937902 was registered on 31 May 2024.
Ceased
Mayur Natvarlal Devani ceased to be Additional Director.
Appointed
Mayur Natvarlal Devani was appointed as Additional Director.
Appointed
Prakashbhai Kalubhai Goti was appointed as Director.
Appointed
Tusharbhai Babubhai Mangukiya was appointed as Director.
Incorporation
03 Jan 2019
Janveda Formulation Private Limited was registered on 03 Jan 2019 with Roc Ahmedabad & aged 7 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Janveda Formulation Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Janveda Formulation Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Janveda Formulation Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Janveda Formulation Private Limited
Janveda Formulation has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECJ4329C1ZZ | Gujarat | Active | 29 Jan 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Janveda Formulation Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Janveda Formulation Private Limited
Janveda Formulation is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U74999GJ2019PTC105848.
Janveda Formulation reported revenue of ₹27.86 Lakh for FY 2025 (down 68% YoY).
Janveda Formulation has 2 current directors:
- Tusharbhai Babubhai Mangukiya - Director
- Prakashbhai Kalubhai Goti - Director
Janveda Formulation reported a net loss of ₹5.35 Lakh (net margin -19.2%) and EBITDA of -₹97,480 (EBITDA margin -3.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Janveda Formulation is -33% over three years and -15% over five years. In the latest year (FY 2025) revenue fell 68%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Janveda Formulation is 24AAECJ4329C1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of Janveda Formulation is U74999GJ2019PTC105848. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Janveda Formulation was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Janveda Formulation by revenue are Newnano Technologies Private Limited, Rising Flora Biotech Private Limited, Valasys Lifesciences Private Limited, Clear Gems Private Limited, Gale Pharma (India) Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayur Natvarlal Devani ceased to be Additional Director on 01 Apr 2023. Mayur Natvarlal Devani was appointed as Additional Director on 14 Nov 2022. Prakashbhai Kalubhai Goti was appointed as Director on 03 Jan 2019. Janveda Formulation has 4 board changes on record in total.
Yes, Janveda Formulation is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0068786).